This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
zacks-consensus-estimate: Archive
Agilent (A) Down 2.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
APositive Net Change MDTNegative Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Abercrombie (ANF) Down 9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Abercrombie (ANF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ANFNegative Net Change TPRPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Lifecore Biomedical (LFCR) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
by Zacks Equity Research
Lifecore Biomedical (LFCR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LFCRPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Why Walmart (WMT) is a Top Stock for the Long-Term
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
WMTPositive Net Change
earnings-estimates growth-investing zacks-consensus-estimate zacks-rank
Costco (COST) Surpasses Q4 Earnings Estimates
by Zacks Equity Research
Costco (COST) delivered earnings and revenue surprises of +1.03% and -0.03%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?
COSTNegative Net Change BBBYPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Concentrix Corporation (CNXC) Q3 Earnings Miss Estimates
by Zacks Equity Research
Concentrix (CNXC) delivered earnings and revenue surprises of -3.47% and +1.02%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?
CNXCNegative Net Change HCSGNo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
What Makes Atlas Copco (ATLKY) a New Buy Stock
by Zacks Equity Research
Atlas Copco (ATLKY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ATLKYNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About KT Corp. (KT) Rating Upgrade to Strong Buy
by Zacks Equity Research
KT Corp. (KT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
KTNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Quipt Home Medical (QIPT) Rating Upgrade to Buy
by Zacks Equity Research
Quipt Home Medical (QIPT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
QIPTNo Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes Hillman Solutions Corp. (HLMN) a New Buy Stock
by Zacks Equity Research
Hillman Solutions Corp. (HLMN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
HLMNPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Gentex (GNTX) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Gentex (GNTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
GNTXPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Trip.com (TCOM) Rating Upgrade to Strong Buy
by Zacks Equity Research
Trip.com (TCOM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
TCOMPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Collegium Pharmaceutical (COLL) Rating Upgrade to Strong Buy
by Zacks Equity Research
Collegium Pharmaceutical (COLL) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
COLLNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
CAMP4 Therapeutics Corporation (CAMP) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
CAMP4 Therapeutics Corporation (CAMP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
CAMPNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About VEON (VEON) Rating Upgrade to Strong Buy
by Zacks Equity Research
VEON (VEON) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
VEONNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Holley (HLLY) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Holley (HLLY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
HLLYPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Why Is Box (BOX) Down 0.4% Since Last Earnings Report?
by Zacks Equity Research
Box (BOX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
BOXPositive Net Change ZMPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Okta (OKTA) Down 3.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Okta (OKTA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
OKTANegative Net Change PANWPositive Net Change
earnings earnings-estimates earnings-performance earnings-report earnings-trend revenue zacks-consensus-estimate
Wall Street Analysts Think US Gold Corp (USAU) Could Surge 28.97%: Read This Before Placing a Bet
by Zacks Equity Research
The mean of analysts' price targets for US Gold Corp (USAU) points to a 29% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
USAUPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
HCAPositive Net Change
earnings-estimates growth-investing zacks-consensus-estimate zacks-rank
Jabil (JBL) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Jabil (JBL) delivered earnings and revenue surprises of +11.53% and +7.67%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?
JBLPositive Net Change PLXSPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
CarMax (KMX) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
CarMax (KMX) delivered earnings and revenue surprises of -37.86% and -6.52%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?
KMXNegative Net Change ORLYPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Accenture (ACN) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Accenture (ACN) delivered earnings and revenue surprises of +1.68% and +1.56%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?
ACNPositive Net Change ASGNPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
TD SYNNEX (SNX) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
TD SYNNEX (SNX) delivered earnings and revenue surprises of +18.54% and +3.41%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?
SNXPositive Net Change TERPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
KB Home (KBH) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
KB Home (KBH) delivered earnings and revenue surprises of +7.33% and +1.50%, respectively, for the quarter ended August 2025. Do the numbers hold clues to what lies ahead for the stock?
KBHPositive Net Change TPHPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank